Guaifenesin and Pradaxa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Guaifenesin (guaifenesin) and Pradaxa (dabigatran etexilate mesylate). Common drug interactions include pharyngeal mass among females and gastrointestinal haemorrhage among males.
The phase IV clinical study analyzes what interactions people have when they take Guaifenesin and Pradaxa. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.
What is Guaifenesin?
Guaifenesin has active ingredients of guaifenesin. It is often used in cough. eHealthMe is studying from 12,106 Guaifenesin users. Check the latest studies of Guaifenesin.
What is Pradaxa?
Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 86,906 Pradaxa users. Check the latest studies of Pradaxa.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
100 people who take Guaifenesin and Pradaxa together, and have interactions are studied.

What are the common drug interactions of Guaifenesin and Pradaxa, by gender? *:
female:
- Pharyngeal mass
- Retching (strong involuntary effort to vomit)
- Skin fissures (a crack in the skin)
- Sleep disorder
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Vertigo
- Vision blurred
- Vomiting
- Coagulopathy (blood's ability to clot is impaired)
- Haematochezia (passage of stools containing blood)
male:
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Anaemia (lack of blood)
- Pleural effusion (water on the lungs)
- Cerebral haemorrhage (bleeding within the brain)
- Fall
- Pneumonia
- Retinal haemorrhage (bleeding from retina)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Ankle fracture
- Anxiety
What are the common drug interactions of Guaifenesin and Pradaxa, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Chronic kidney disease
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
50-59:
- Coagulopathy (blood's ability to clot is impaired)
- Epistaxis (bleed from the nose)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
- Multiple fractures
- Renal failure (kidney dysfunction)
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Chronic kidney disease
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Ankle fracture
60+:
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Anaemia (lack of blood)
- Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
- Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
- Device occlusion
- Gait disturbance
- Decreased appetite
- Headache (pain in head)
- Hypertension (high blood pressure)
- Malaise (a feeling of general discomfort or uneasiness)
What are the existing conditions these people have? *
- Pain: 20 people, 20.00%
- High Blood Pressure: 15 people, 15.00%
- Constipation: 13 people, 13.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 10.00%
- Chest Pain: 10 people, 10.00%
- Insomnia (sleeplessness): 9 people, 9.00%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 9 people, 9.00%
- Fever: 7 people, 7.00%
- Dyspnea (difficult or laboured breathing): 7 people, 7.00%
- Stress And Anxiety: 7 people, 7.00%
* Approximation only. Some reports may have incomplete information.
Do you take Guaifenesin and Pradaxa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Guaifenesin (12,106 reports)
- Pradaxa (86,906 reports)
Browse all drug interactions of Guaifenesin and Pradaxa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Guaifenesin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pradaxa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Guaifenesin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pradaxa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on guaifenesin and dabigatran etexilate mesylate (the active ingredients of Guaifenesin and Pradaxa, respectively), and Guaifenesin and Pradaxa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lantus Solostar cause Intervertebral Disc Disorder? - 6 seconds ago
- Could Benzonatate cause Drug Ineffective? - 19 seconds ago
- Could Tequin cause Intervertebral Disc Protrusion? - 20 seconds ago
- Could Tpn cause Sinusitis - Acute? - 21 seconds ago
- Could Tpn cause Sinusitis? - 21 seconds ago
- Gastritis Aggravated and Speech Impairment (Adult) - 22 seconds ago
- Could Dupixent cause Foot Fracture? - 22 seconds ago
- Drug interactions of Altace and Lipitor - 25 seconds ago
- Could Losartan cause Allergy To Vaccine? - 27 seconds ago
- Could Oxsoralen-Ultra cause Stress And Anxiety? - 28 seconds ago